Guarding Health,
Shielding Futures

Continuous Defense Technologies to
Combat Healthcare Infections and Antimicrobial Resistance

Leading the Charge Against Antimicrobial Resistance

We are committed to saving lives through innovation, focusing on the creation of cleaner surfaces to combat infection.

Technology Pipeline

Program

Microbicidal Coating Technology
Keep Klear

Continuously active transparent microbicidal coating technology: offering a  7-day residual effect

  1. Discovery
  2. Preclinical
  3. Phase1
  4. Phase2
  1. Discovery
  2. Preclinical
  3. Phase1
  4. Phase2

Partners

Antimicrobial Fabric Technology
Micro Dome®

Antimicrobial fabrics: Safeguarding healthcare settings by inhibiting the growth of drug-resistant pathogens

  1. Discovery
  2. Preclinical
  3. Phase1
  4. Phase2
Confidential
Adjuvant Antibiotic Platform
PRP-2019

Optimizing inactive commercial antibiotics for infectious diseases: Boosting effectiveness with adjuvant antibiotic technology

  1. Discovery
  2. Preclinical
  3. Phase1
  4. Phase2

Challenges Overview

AMR

Antimicrobial Resistance (AMR) presents a critical global challenge, rendering conventional treatments ineffective against infections. Without urgent action, common ailments may become untreatable, posing grave risks to public health and healthcare systems worldwide

HAI

Hospital Acquired Infections (HAIs) pose a serious threat, leading to prolonged hospital stays, increased healthcare costs, and even mortality. Preventable with stringent hygiene protocols, HAIs underscore the importance of proactive measures to ensure patient safety and well-being

Science Spotlight: Insights & Innovations